CREB-binding protein bromodomain (human recombinant) |
Source: Recombinant N-terminal GST-tagged protein expressed in E. coli &bu… |
100 µg |
11288-100 |
More Info
|
CREB (Phospho-Ser133) Transcription Factor Assay Kit |
CREB (cAMP-response-element-binding protein) is a transcription factor tha… |
96 Well |
10009846-96WELLS |
More Info
|
CREB (Phospho-Ser133) TR-FRET Assay Kit |
This CREB (Phospho-Ser133) TR-FRET Assay Kit uses a homogeneous TR-FRET as… |
2400 Well |
500243-2400WELLS |
More Info
|
CREB (Phospho-Ser133) TR-FRET Assay Kit |
This CREB (Phospho-Ser133) TR-FRET Assay Kit uses a homogeneous TR-FRET as… |
480 Well |
500243-480WELLS |
More Info
|
CREB (Phospho-Ser133) TR-FRET Assay Kit |
This CREB (Phospho-Ser133) TR-FRET Assay Kit uses a homogeneous TR-FRET as… |
4800 Well |
500243-4800WELLS |
More Info
|
CREB (Phospho-Ser133) TR-FRET Assay Kit |
This CREB (Phospho-Ser133) TR-FRET Assay Kit uses a homogeneous TR-FRET as… |
96 Well |
500243-96WELLS |
More Info
|
CREB (Phospho-Ser133) TR-FRET Assay Kit |
This CREB (Phospho-Ser133) TR-FRET Assay Kit uses a homogeneous TR-FRET as… |
9600 Well |
500243-9600WELLS |
More Info
|
CREB (Total) and CREB (Phospho-Ser133) TR-FRET Assay Kit |
This CREB (Total) and CREB (Phospho-Ser133) TR-FRET Assay Kit uses a homog… |
480 Well |
500245-480WELLS |
More Info
|
CREB (Total) TR-FRET Assay Kit |
This CREB (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay metho… |
2400 Well |
500244-2400WELLS |
More Info
|
CREB (Total) TR-FRET Assay Kit |
This CREB (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay metho… |
480 Well |
500244-480WELLS |
More Info
|
CREB (Total) TR-FRET Assay Kit |
This CREB (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay metho… |
4800 Well |
500244-4800WELLS |
More Info
|
CREB (Total) TR-FRET Assay Kit |
This CREB (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay metho… |
96 Well |
500244-96WELLS |
More Info
|
CREB (Total) TR-FRET Assay Kit |
This CREB (Total) TR-FRET Assay Kit uses a homogeneous TR-FRET assay metho… |
9600 Well |
500244-9600WELLS |
More Info
|
Crenigacestat |
A Notch inhibitor; induces cell cycle arrest at the G0 / G1 phase and decr… |
1 mg |
27919-1 |
More Info
|
Crenigacestat |
A Notch inhibitor; induces cell cycle arrest at the G0 / G1 phase and decr… |
10 mg |
27919-10 |
More Info
|
Crenigacestat |
A Notch inhibitor; induces cell cycle arrest at the G0 / G1 phase and decr… |
5 mg |
27919-5 |
More Info
|
Crenolanib |
An orally bioavailable, selective inhibitor of PDGFRα, PDGFRβ,… |
1 mg |
18873-1 |
More Info
|
Crenolanib |
An orally bioavailable, selective inhibitor of PDGFRα, PDGFRβ,… |
10 mg |
18873-10 |
More Info
|
Crenolanib |
An orally bioavailable, selective inhibitor of PDGFRα, PDGFRβ,… |
5 mg |
18873-5 |
More Info
|
Crenolanib |
An orally bioavailable, selective inhibitor of PDGFRα, PDGFRβ,… |
50 mg |
18873-50 |
More Info
|
C24 (2'(R)-hydroxy) Ceramide (d18:1/24:0) |
A synthetic ceramide; has been used in the preparation of synthetic lipid… |
1 mg |
22527-1 |
More Info
|
C24 (2'(R)-hydroxy) Ceramide (d18:1/24:0) |
A synthetic ceramide; has been used in the preparation of synthetic lipid… |
5 mg |
22527-5 |
More Info
|
C24 (2'(R)-hydroxy) dihydro Ceramide (d18:0/24:0) |
A hydroxylated dihydro ceramide |
1 mg |
28935-1 |
More Info
|
C24 (2'(R)-hydroxy) Phytoceramide (t18:0/24:0) |
A naturally occurring sphingolipid; inhibits LPS-induced NO production in… |
1 mg |
28933-1 |
More Info
|
Cridanimod (sodium salt) |
An inducer of type I interferon production; induces IRF3 phosphorylation,… |
1 mg |
27884-1 |
More Info
|
Cridanimod (sodium salt) |
An inducer of type I interferon production; induces IRF3 phosphorylation,… |
10 mg |
27884-10 |
More Info
|
Cridanimod (sodium salt) |
An inducer of type I interferon production; induces IRF3 phosphorylation,… |
5 mg |
27884-5 |
More Info
|
cRIPGBM |
An active metabolite of RIPGBM; formed from RIPGBM selectively in GBM1 CSC… |
10 mg |
38115-10 |
More Info
|
cRIPGBM |
An active metabolite of RIPGBM; formed from RIPGBM selectively in GBM1 CSC… |
25 mg |
38115-25 |
More Info
|
cRIPGBM |
An active metabolite of RIPGBM; formed from RIPGBM selectively in GBM1 CSC… |
5 mg |
38115-5 |
More Info
|
CRL-40,941 |
An analytical reference standard categorized as a nootropic; intended for… |
1 mg |
19138-1 |
More Info
|
CRL-40,941 |
An analytical reference standard categorized as a nootropic; intended for… |
5 mg |
19138-5 |
More Info
|
Crocin/Gardenia Extract |
A Gardenia extract that contains crocin I, II, and III, and crocetin, amon… |
1 g |
26337-1 |
More Info
|
Crocin/Gardenia Extract |
A Gardenia extract that contains crocin I, II, and III, and crocetin, amon… |
5 g |
26337-5 |
More Info
|
Crocin/Gardenia Extract |
A Gardenia extract that contains crocin I, II, and III, and crocetin, amon… |
500 mg |
26337-500 |
More Info
|
Cromolyn (sodium salt hydrate) |
A chromone complex that acts as a mast cell stabilizer to prevent the rele… |
1 g |
21379-1 |
More Info
|
Cromolyn (sodium salt hydrate) |
A chromone complex that acts as a mast cell stabilizer to prevent the rele… |
10 g |
21379-10 |
More Info
|
Cromolyn (sodium salt hydrate) |
A chromone complex that acts as a mast cell stabilizer to prevent the rele… |
25 g |
21379-25 |
More Info
|
Cromolyn (sodium salt hydrate) |
A chromone complex that acts as a mast cell stabilizer to prevent the rele… |
5 g |
21379-5 |
More Info
|
Cropropamide |
A component of prethcamide; increases locomotor activity in rats at 33.69… |
10 mg |
30888-10 |
More Info
|
Cropropamide |
A component of prethcamide; increases locomotor activity in rats at 33.69… |
25 mg |
30888-25 |
More Info
|
Cropropamide |
A component of prethcamide; increases locomotor activity in rats at 33.69… |
5 mg |
30888-5 |
More Info
|
Crosstide (trifluoroacetate salt) |
A peptide substrate for Akt; corresponds to the amino acid sequence of GSK… |
1 mg |
36889-1 |
More Info
|
Crosstide (trifluoroacetate salt) |
A peptide substrate for Akt; corresponds to the amino acid sequence of GSK… |
10 mg |
36889-10 |
More Info
|
Crosstide (trifluoroacetate salt) |
A peptide substrate for Akt; corresponds to the amino acid sequence of GSK… |
5 mg |
36889-5 |
More Info
|
Crotamiton |
An ectoparasiticide and antipruritic agent; blocks mouse TRPV4 channel exp… |
100 mg |
23943-100 |
More Info
|
Crotonoside |
A guanosine analog with diverse biological activities; cytotoxic to P338,… |
1 mg |
28219-1 |
More Info
|
Crotonoside |
A guanosine analog with diverse biological activities; cytotoxic to P338,… |
10 mg |
28219-10 |
More Info
|
Crotonoside |
A guanosine analog with diverse biological activities; cytotoxic to P338,… |
25 mg |
28219-25 |
More Info
|
Crotonoside |
A guanosine analog with diverse biological activities; cytotoxic to P338,… |
5 mg |
28219-5 |
More Info
|
Crotonyl fentanyl-d5 |
An internal standard for the quantification of crotonyl fentanyl by GC- or… |
1 mg |
25132-1 |
More Info
|
Crotonyl fentanyl-d5 |
An internal standard for the quantification of crotonyl fentanyl by GC- or… |
500 µg |
25132-500 |
More Info
|
Crotonyl fentanyl (exempt preparation) |
An analytical reference material categorized as an opioid; induces general… |
100 µg |
39889-100 |
More Info
|
CRT0036521 |
An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… |
100 mg |
36600-100 |
More Info
|
CRT0036521 |
An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… |
250 mg |
36600-250 |
More Info
|
CRT0036521 |
An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… |
50 mg |
36600-50 |
More Info
|
CRT0036521 |
An inhibitor of prostaglandin F synthase / AKR1C3 (IC50 = 0.013 µM);… |
500 mg |
36600-500 |
More Info
|
CRT0066854 |
A PKCι and PKCζ inhibitor (IC50s = 132 and 639 nM, respectively)… |
1 mg |
28463-1 |
More Info
|
CRT0066854 |
A PKCι and PKCζ inhibitor (IC50s = 132 and 639 nM, respectively)… |
10 mg |
28463-10 |
More Info
|
CRT0066854 |
A PKCι and PKCζ inhibitor (IC50s = 132 and 639 nM, respectively)… |
5 mg |
28463-5 |
More Info
|
CRT0273750 |
An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… |
1 mg |
20904-1 |
More Info
|
CRT0273750 |
An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… |
10 mg |
20904-10 |
More Info
|
CRT0273750 |
An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… |
25 mg |
20904-25 |
More Info
|
CRT0273750 |
An ENPP2 inhibitor (IC50 = 1 nM); prevents lysophosphatidylcholine hydroly… |
5 mg |
20904-5 |
More Info
|
CRT5 |
A pyrazine benzamide that prevents activation of all three isoforms of PKD… |
1 mg |
18532-1 |
More Info
|
CRT5 |
A pyrazine benzamide that prevents activation of all three isoforms of PKD… |
10 mg |
18532-10 |
More Info
|
CRT5 |
A pyrazine benzamide that prevents activation of all three isoforms of PKD… |
25 mg |
18532-25 |
More Info
|
CRT5 |
A pyrazine benzamide that prevents activation of all three isoforms of PKD… |
5 mg |
18532-5 |
More Info
|
CRTH2/DP2 Receptor (C-Term) Blocking Peptide |
Peptide Sequence: CRTH2 / DP2 protein amino acids 378-395 · To be u… |
1 ea |
10007003-1 |
More Info
|
CRTH2/DP2 Receptor (N-Term) Blocking Peptide |
Peptide Sequence: CRTH2 / DP2 protein amino acids 2-21 · To be used… |
1 ea |
10004884-200 |
More Info
|
CRT0066101 (hydrochloride) |
A pan inhibitor PKD (IC50s = 1, 2.5, and 2 nM for PKD1, PKD2, and PKD3, re… |
1 mg |
15337-1 |
More Info
|
CRT0066101 (hydrochloride) |
A pan inhibitor PKD (IC50s = 1, 2.5, and 2 nM for PKD1, PKD2, and PKD3, re… |
10 mg |
15337-10 |
More Info
|
CRT0066101 (hydrochloride) |
A pan inhibitor PKD (IC50s = 1, 2.5, and 2 nM for PKD1, PKD2, and PKD3, re… |
5 mg |
15337-5 |
More Info
|
Cruzain-IN-1 |
An inhibitor of cruzain (IC50 = 0.2 nM); selective for cruzain over cathep… |
1 mg |
37350-1 |
More Info
|
Cruzain-IN-1 |
An inhibitor of cruzain (IC50 = 0.2 nM); selective for cruzain over cathep… |
10 mg |
37350-10 |
More Info
|